*** Need an answer to your GCP query ? Post your query at HelpDesk ***
Follow us on




Process validation

Establishing by objective evidence that a process consistently produces a result or product meeting its predetermined specifications.

 Forums
Welcome Guest   [Register]  [Login]
EFGCP–EUCROF Joint Workshop Final Report   by  on 2010-08-20 12:12:20
Managing Clinical Trials   by  on 2010-07-15 16:05:32
US-FDA issues Revised Info Sheet Guidance on Clinical Investigator Disqualification   by  on 2010-06-13 10:11:41
US-FDA issues final guidance on Statement of Investigator (Form FDA 1572)   by  on 2010-06-13 10:07:59
Rising Clinical Trial Complexity Continues to Vex Drug Developers   by  on 2010-06-03 09:36:33
Investigator-Driven Clinical Trials: An ESF Forward Look   by  on 2010-06-03 09:27:58
NIH's Financial Conflict of Interest (FCOI) Proposed Rule   by  on 2010-05-27 11:42:00
AAP’s Guidelines for the Ethical Conduct of Studies to Evaluate Drugs in Pediatric Population   by  on 2010-05-13 11:39:54
Argentina: ANMAT - new regulatory update   by  on 2010-05-01 01:40:32
 Subject :US FDA Warning Letters in Clinical Investigation for the Month of Dece.. 2009-12-31 09:10:00 
GCP HelpDesk
Moderator
Joined: 2009-06-18 15:31:58
Posts: 62
Location
Subject :US FDA Warning Letters in Clinical Investigation for the Month of December 2009

Dear Friends,

Please find attached US FDA warning letter for the month of December 2009.

Thanks and regards,



Attachments
 December 2009.pdf [25 KB] ::
IP Logged
GCP HelpDesk
Page # 


Powered by ccBoard